Status:
ACTIVE_NOT_RECRUITING
Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Malignant Neoplasm
Eligibility:
All Genders
18+ years
Brief Summary
This clinical trial studies a novel single wave assessment in measuring cardiac dysfunction and metabolic syndrome in patients with cancer. The novel single wave assessment is a hand held device that ...
Detailed Description
PRIMARY OBJECTIVES: I. To determine the relationship between insulin resistance (delta omega) as measured by the single wave application and inflammation markers associated with insulin resistance an...
Eligibility Criteria
Inclusion
- Adult patients undergoing 2D echocardiogram at City of Hope (COH)
- Patients with a current or past diagnosis of cancer
- Ability to sign a written informed consent
Exclusion
- Inability to provide informed consent
- Patients who have known "carotid sinus hypersensitivity"
- Patients who do not consent to blood draw
- Patients who have not fasted for the instructed time prior to blood draw
Key Trial Info
Start Date :
July 21 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 11 2026
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT04014231
Start Date
July 21 2017
End Date
May 11 2026
Last Update
July 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010